Anlotinib in Cross-line Treatment of NSCLC and SCLC

Clinical trial NCT07400575 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07400575
Sponsor: Henan Cancer Hospital
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

NSCLC (Advanced Non-small Cell Lung Cancer)SCLC, Extensive Stage

Start date: 2026-02-01
Primary completion: 2026-12-31
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.